U.S. Congress - S.27 Preserve Access to Affordable Generics Act
S.27 - Preserve Access to Affordable Generics Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. view all titles (3)
All Bill Titles
- Official: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. as introduced.
- Short: Preserve Access to Affordable Generics Act as introduced.
- Short: Preserve Access to Affordable Generics Act as reported to senate.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| All Actions | |
|---|---|
| Jan 25th | Sponsor introductory remarks on measure. (CR S143-144) |
| Jan 25th | Read twice and referred to the Committee on the Judiciary. |
| Jan 25th | Introduced in Senate |
| Jul 14th | Committee on the Judiciary. Date of scheduled consideration. SD-226. 10:00 a.m. |
| Jul 21st | Committee on the Judiciary. Ordered to be reported without amendment favorably. |
| Jul 21st | Committee on the Judiciary. Date of scheduled consideration. SD-226. 10:00 a.m. |
| Jul 22nd | Placed on Senate Legislative Calendar under General Orders. Calendar No. 110. |
| Jul 22nd | Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report. |
Vote on This Bill
-
Share This Bill
More Share via Email
